RxDoctor Payments Data

Vishaal Mehra

Psychiatry · San Diego, CANPI 1144472754

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,480 of the $1,480 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, F. Hoffmann-la Roche AG.

$1,480in general payments, 2019–2025

Across 1 payment — averaging $1480.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • F. Hoffmann-la Roche AG$1K
$1,024,065in research payments, 2019–2025

Across 172 payments — averaging $5953.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$423K
  • AbbVie$306K
  • Roche TCRC, Inc.$96K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52K
  • Tolmar, Inc.$43K
  • Takeda Pharmaceuticals U.S.A., Inc.$29K
  • plus $75K from 5 others

What the payments were for

  • Consulting fees$1,480100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
F. Hoffmann-la Roche AG1$1,480

How this compares

$1,480 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in San Diego

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →